• Media type: E-Article
  • Title: Vena cava thrombus in patients with wilms tumor
  • Contributor: Meier, Clemens-Magnus [Author]; Furtwängler, Rhoikos [Author]; Schweinitz, Dietrich von [Author]; Stein, Raimund [Author]; Welter, Nils [Author]; Wagenpfeil, Stefan [Author]; Kager, Leo [Author]; Schenk, Jens-Peter [Author]; Vokuhl, Christian Oliver [Author]; Melchior, Patrick [Author]; Fuchs, Jörg [Author]; Graf, Norbert [Author]
  • Published: 14 August 2022
  • Published in: Cancers ; 14(2022), 16, Artikel-ID 3924, Seite 1-11
  • Language: English
  • DOI: 10.3390/cancers14163924
  • Identifier:
  • Keywords: preoperative chemotherapy ; surgery ; treatment ; vena cava thrombus ; Wilms tumor
  • Origination:
  • Footnote: Der Artikel ist Teil des Special Issue: New insights in pediatric surgical oncology
  • Description: (1) Background: Vena cava thrombus (VCT) is rare in Wilms tumor (WT) (4-10%). The aim of this study is to identify factors for an outcome to improve treatment for better survival. (2) Methods: 148/3015 patients with WT (aged < 18 years) and VCT, prospectively enrolled over a period of 32 years (1989-2020) by the German Society for Pediatric Oncology and Hematology (SIOP-9/GPOH, SIOP-93-01/GPOH and SIOP-2001/GPOH), are retrospectively analyzed to describe clinical features, response to preoperative chemotherapy (PC) (142 patients) and surgical interventions and to evaluate risk factors for overall survival (OS). (3) Results: 14 VCT regressed completely with PC and another 12 in parts. The thrombus was completely removed in 111 (85.4%), incompletely in 16 (12.3%), and not removed in 3 (2.3%). The type of removal is unknown in four patients. Patients without VCT have a significantly (p < 0.001) better OS (97.8%) than those with VCT (90.1%). OS after complete resection is (89.9%), after incomplete (93.8%) and with no resection (100%). Patients with anaplasia or stage IV without complete remission (CR) after PC had a significantly worse OS compared to the remaining patients with VCT (77.1% vs. 94.4%; p = 0.002). (4) Conclusions: As a result of our study, two risk factors for poor outcomes in WT patients with VCT emerge: diffuse anaplasia and metastatic disease, especially those with non-CR after PC.
  • Access State: Open Access